CNRS, UMR 6290, Rennes, France; Université de Rennes 1, UBL, Genetics and Development Institute of Rennes (IGDR), Rennes, France
Anne-Laure Bulteau
ENS de Lyon, Lyon, France; CNRS UMR 5242, Lyon, France; INRA USC 1370, Lyon, France
Marie-Clotilde Alves-Guerra
Inserm, U1016, Institut Cochin, Paris, France; CNRS, UMR 8104, Paris, France; Université Paris Descartes, Sorbonne Paris Cité, Paris, France
Agnes Burel
Microscopy Rennes Imaging Centre, SFR Biosit, UMS CNRS 3480- US INSERM 018, Université de Rennes, Rennes, France
Marie-Thérèse Lavault
Microscopy Rennes Imaging Centre, SFR Biosit, UMS CNRS 3480- US INSERM 018, Université de Rennes, Rennes, France
Olivia Gavard
CNRS, UMR 6290, Rennes, France; Université de Rennes 1, UBL, Genetics and Development Institute of Rennes (IGDR), Rennes, France; Equipes labélisées Ligue Contre Le Cancer, Rennes, France; Centre de recherche du CHU de Québec, Faculté de Médecine, Université Laval, Québec, Canada
Stephanie Le Bras
CNRS, UMR 6290, Rennes, France; Université de Rennes 1, UBL, Genetics and Development Institute of Rennes (IGDR), Rennes, France
Jean-Philippe Gagné
Centre de recherche du CHU de Québec, Faculté de Médecine, Université Laval, Québec, Canada
Guy G Poirier
Centre de recherche du CHU de Québec, Faculté de Médecine, Université Laval, Québec, Canada
CNRS, UMR 6290, Rennes, France; Université de Rennes 1, UBL, Genetics and Development Institute of Rennes (IGDR), Rennes, France; Equipes labélisées Ligue Contre Le Cancer, Rennes, France
CNRS, UMR 6290, Rennes, France; Université de Rennes 1, UBL, Genetics and Development Institute of Rennes (IGDR), Rennes, France; Equipes labélisées Ligue Contre Le Cancer, Rennes, France
CNRS, UMR 6290, Rennes, France; Université de Rennes 1, UBL, Genetics and Development Institute of Rennes (IGDR), Rennes, France; Microscopy Rennes Imaging Centre, SFR Biosit, UMS CNRS 3480- US INSERM 018, Université de Rennes, Rennes, France
Many epithelial cancers show cell cycle dysfunction tightly correlated with the overexpression of the serine/threonine kinase Aurora A (AURKA). Its role in mitotic progression has been extensively characterised, and evidence for new AURKA functions emerges. Here, we reveal that AURKA is located and imported in mitochondria in several human cancer cell lines. Mitochondrial AURKA impacts on two organelle functions: mitochondrial dynamics and energy production. When AURKA is expressed at endogenous levels during interphase, it induces mitochondrial fragmentation independently from RALA. Conversely, AURKA enhances mitochondrial fusion and ATP production when it is over-expressed. We demonstrate that AURKA directly regulates mitochondrial functions and that AURKA over-expression promotes metabolic reprogramming by increasing mitochondrial interconnectivity. Our work paves the way to anti-cancer therapeutics based on the simultaneous targeting of mitochondrial functions and AURKA inhibition.